Company

Edgewood Oncology

https://www.edgewoodoncology.com/

Industrya Brookline, MA-based clinical-stage biotechnology company focused on delivering BTX-A51 to patients with hematologic malignancies and genetically-defined solid tumors

Funding raised

CompanyRoundDate
Edgewood OncologySeries A Funding2024-03-25